Skip to search formSkip to main contentSkip to account menu

Estramustine phosphate

Known as: Estramustin Phosphate, Estramustinphosphate, Phosphate, Estramustin 
National Institutes of Health

Related topics

Related topics

4 relations

Narrower (2)

EmcytEstracyt

Broader (1)

Estramustine
Estramustine Phosphate Sodium

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Pilot study on the growth inhibition by estramustine phosphate (Estracyt) of rat mammary tumours sensitive and insensitive of oestrogen.
Rat mammary tumours induced by 7,12-dimethylbenz(a)anthracene had a higher concentration of 3H and 14C than muscle after… 
2004
2004
Pharmacokinetics of estramustine phosphate (Estracyt®) in prostatic cancer patients
SummaryThe pharmacokinetics of estramustine phosphate (EMP) was studied in five prostatic cancer patients given single i.v. and… 
1991
1991
Binding Sites for the Cytotoxic Metabolites of Estramustine Phosphate (Estracyt) in Rat and Human Pancreas that are Distinct from Pancreatic Estrogen‐Binding Protein
The interaction of estramustine and estromustine, cytotoxic metabolites of estramustine phosphate (Estracyt), with protein… 
1987
1987
Estrogen receptor and binding site for estramustine in metastatic malignant melanoma.
Enzyme immuno assay (EIA) of estrogen receptor (ER) has confirmed the results of earlier investigations using steroid binding… 
Highly Cited
1985
Highly Cited
1985
Effect of estramustine phosphate on the assembly of isolated bovine brain microtubules and fast axonal transport in the frog sciatic nerve.
Estramustine phosphate (0.01 to 0.5 mM), an estradiol mustard derivative used in the therapy of prostatic carcinoma, inhibited… 
Highly Cited
1982
Highly Cited
1982
Partial characterization and "quantitation" of a human prostatic estramustine-binding protein.
The [3H]estramustine-binding macromolecule in human prostate was partially characterized using a number of chromatographic… 
1981
1981
Plasma concentrations of estramustine phosphate and its major metabolites in patients with prostatic carcinoma treated with different doses of estramustine phosphate (Estracyt).
Plasma concentrations of estramustine phosphate and its major metabolites were measured in patients with prostatic carcinoma… 
1981
1981
Effect of treatment with diethylstilbestrol-polyestradiol phosphate or estramustine phosphate (estracyt) on natural killer cell activity in patients with prostatic cancer.
We evaluated the effect of treatment of patients with prostatic cancer with estramustine phosphate or the combination… 
1980
1980
Estramustine phosphate in the treatment of advanced prostatic cancer.
Thirty patients with advanced carcinoma of the prostate were treated with estramustine phosphate. All patients were followed up… 
1973
1973
Histochemical and biochemical investigation of advanced prostatic carcinoma treated with estramustine phosphate, Estracyt.
The activity and distribution of five hydrolytic enzymes in human prostatic carcinomatous tissue were studied before and during… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)